Qualys (QLYS) News Roundup for Nov. 7–8, 2025: Analyst Upgrade, EPS Estimate Lift, and Stock Holds Near $150 After Q3 Beat

Qualys (QLYS) News Roundup for Nov. 7–8, 2025: Analyst Upgrade, EPS Estimate Lift, and Stock Holds Near $150 After Q3 Beat

Dateline: November 8, 2025 — Cybersecurity vendor Qualys, Inc. (NASDAQ: QLYS) stayed in the headlines heading into the weekend, with fresh analyst reactions following Tuesday’s earnings beat, a state pension fund disclosing a larger stake, and continued chatter around its agentic‑AI roadmap. Below is a concise, Google News–ready digest of everything new about Qualys published November 7–8, 2025.


Key Points at a Glance

  • Upgrade today: Wall Street Zen shifted QLYS to “Buy.” (MarketBeat summary). [1]
  • Forecast lift: William Blair raised its Q1‑2026 EPS estimate to $1.26 (from $1.12), citing stronger near‑term profitability. (MarketBeat summary). [2]
  • Institutional activity (Nov. 7):STRS Ohio disclosed it boosted its Qualys holdings last quarter. (MarketBeat filing brief). [3]
  • Price context (today):QLYS last traded around $149.73; 52‑week range $112.61–$159.73, per Reuters. [4]
  • Why the attention: On Nov. 4, Qualys beat Q3 expectations and raised full‑year guidance (revenue to $665.8–$667.8M; non‑GAAP EPS to $6.93–$7.00). [5]

Today — Saturday, Nov. 8, 2025

Analyst upgrade to “Buy.” MarketBeat reports that Wall Street Zen upgraded Qualys shares to Buy today, pointing to the company’s updated FY25 outlook following this week’s results. While this is one datapoint among a mixed street view, upgrades often keep post‑earnings momentum in focus. [6]

EPS estimate raised. In a separate note highlighted by MarketBeat, William Blair lifted its Q1‑2026 EPS estimate to $1.26 (from $1.12). That upward revision reflects improving operating leverage after Qualys’ Q3 delivery and updated guide. [7]

Price snapshot. As of today, Reuters shows QLYS around $149.73, with a 52‑week band of $112.61–$159.73—placing shares closer to the upper end of their one‑year range post‑earnings. [8]

Momentum chatter. A Saturday technical read from StockTradersDaily flagged “near‑term strong sentiment” but noted a neutral medium‑ to long‑term setup—another sign traders are still digesting this week’s results. [9]

Media mention (AI angle). Yahoo Finance featured a weekend story on “under‑the‑radar” AI names that included Qualys, citing its work on agentic AI in risk operations—an area the company formally unveiled over the summer. [10]


Friday, Nov. 7, 2025

State fund adds to QLYS. MarketBeat’s filing roundup says STRS Ohio increased its Qualys stake last quarter. The position change lands one day after Qualys’ report and may be read as a confidence marker from a large institution. [11]

Earnings coverage continues. Yahoo Finance recapped the beat on both revenue (~$170M) and statutory EPS ($1.39), echoing the core numbers investors have been trading on since Tuesday’s release. [12]

Investor explainer piece. Simply Wall St also published a Friday analysis noting shares were sharply higher post‑print and reiterating the updated outlook, keeping the story in front of retail investors into the weekend. [13]

From the Qualys blog (Nov. 7). The company posted a fresh technical write‑up on a large automotive data‑leak case study, tying it to cloud‑misconfiguration lessons for AWS users—useful context for customers evaluating the platform’s risk‑reduction chops. [14]


Context: What Qualys Reported on Nov. 4 (and Why It Matters)

  • Q3 FY25 results:Revenue $169.9M (+10% YoY); non‑GAAP EPS $1.86; GAAP EPS $1.39; Adjusted EBITDA $82.6M with stronger gross and operating margins. [15]
  • Q4 FY25 guide: Revenue $172–$174M; non‑GAAP EPS $1.73–$1.80. [16]
  • Full‑year FY25 guide raised: Revenue to $665.8–$667.8M (about 10% YoY growth) and non‑GAAP EPS to $6.93–$7.00. [17]

These numbers underpinned this week’s rally and set the stage for analysts to revisit models into year‑end.


Strategy & Product Backdrop to the AI Mentions

The weekend AI chatter references Qualys’ summer launch of an agentic AI–powered Risk Operations Center, designed to automate risk workflows with a marketplace of cyber risk agents embedded in the Enterprise TruRisk Management platform. That product direction continues to shape how investors categorize Qualys among AI‑levered security names. [18]


What’s Next on the Calendar

Qualys management is slated to appear at the UBS Global Technology & AI Conference in Scottsdale on Dec. 2, 2025 (2:15 p.m. MT), with a webcast via the company’s investor relations site—another venue where commentary on billings, platform adoption and AI may surface. [19]


Bottom Line

For Nov. 7–8, 2025, the new, incremental developments are an upgrade to Buy, a higher near‑term EPS estimate, fresh institutional‑holder interest, and continued media focus on Qualys’ agentic‑AI positioning. All of it layers on top of Tuesday’s clean beat and raised FY25 guide, helping keep QLYS trading near $150 into the weekend. [20]


Disclosure: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities.

insiders are SELLING! QUALYS Stock’s Biggest Dips – Time to Worry or Buy? 🔍📉

References

1. www.marketbeat.com, 2. www.marketbeat.com, 3. www.marketbeat.com, 4. www.reuters.com, 5. www.prnewswire.com, 6. www.marketbeat.com, 7. www.marketbeat.com, 8. www.reuters.com, 9. news.stocktradersdaily.com, 10. finance.yahoo.com, 11. www.marketbeat.com, 12. finance.yahoo.com, 13. simplywall.st, 14. blog.qualys.com, 15. www.prnewswire.com, 16. www.prnewswire.com, 17. www.prnewswire.com, 18. www.prnewswire.com, 19. www.qualys.com, 20. www.marketbeat.com

Stock Market Today

  • Crypto ETFs Fuel Investor Interest; DeepSnitch AI Presale Surges as AI-Powered Analysis Gains Traction
    November 8, 2025, 2:28 PM EST. New Schwab Asset Management research shows nearly half of ETF investors plan to buy a crypto ETF, with the same share eyeing a bond version, underscoring growing institutional acceptance. Analysts called the results "shocking," noting crypto and bond ETFs are being treated on par in a market that remains 17x smaller. The momentum spills over into future projects and presales, including DeepSnitch AI, which is already raising attention and capital. Its presale has topped $504K with a price of $0.022 and a 45% gain from the initial level. The Schwab survey of 2,000 investors-especially millennials and Gen X-highlights demand for accessible, low-cost exposure to crypto beyond Bitcoin, and a wave of AI-powered presales that blend real-world utility with digital assets.
  • Best Meme Coins to Buy Now: Top 5 Tokens for 100x Gains in 2026
    November 8, 2025, 2:26 PM EST. Amid a choppy crypto market, meme coins remain among the hottest bets as investors chase outsized moves. The piece notes Bitcoin retreating and riskier tokens selling off, even as privacy coins rise and ETF data shows big investors still funding crypto via diverse assets. It then presents a top-5 list, led by DeepSnitch AI (DSNT), the AI-driven meme coin promising real trading intelligence. DSNT leverages algorithms to track whale moves, audit contracts, and flag scams, with a presale at $0.022 (up ~45% from the starting price) and a January 2026 close. Other selections include Shiba Inu (SHIB), the OG meme coin that powered multi-millionaire early investors. The article frames these picks as potential 100x-style opportunities in 2026 for bold traders.
  • Ferrari Stock Looks Expensive - Or Does It? A Deep Dive into the Luxury Compounder's Valuation
    November 8, 2025, 2:24 PM EST. Ferrari (NYSE: RACE) trades at a lofty multiple-P/E around 41, EV/EBITDA near 29, and a price-to-sales above 11-yet its earnings engine isn't typical of autos. With an adjusted EBITDA margin of 38.3%, operating margin ~28%, and ~50% gross margin in 2024, Ferrari sits closer to luxury houses like LVMH and Hermès than to Ford or Toyota. Its business model hinges on scarcity, powerful pricing discipline, and an emotion-driven brand that keeps demand resilient even in slowdowns. About 15% of revenue now comes from sponsorships, licensing, financial services, and after-sales, bolstering consistency. ROIC near 24% and booming free cash flow (up 139% from 2015-2024) fund reinvestment and returns. The key question: is the premium justified by the luxury compounder's growth and margins, or is risk to valuation rising as auto cycles weigh in?
  • Berkshire Hathaway Holds Record Cash as Buffett Stays Cautious on Stock Purchases
    November 8, 2025, 2:22 PM EST. Buffett's Berkshire Hathaway delivered a cautious Q3, continuing net equity selling and a notable cash build while buying a single asset: OxyChem for $9.7B. The firm finished with a record $381.6 billion in cash, bought $6.4B of stocks and sold $12.5B in equities, and skipped share repurchases for a fifth straight quarter. Berkshire trades near 1.5x book value, down from earlier peaks, yet Buffett remains wary of near-term market valuations despite strong operating results across insurance float, rail, and manufacturing. The message: Berkshire is not rushing into new bets; it deploys capital cautiously via its float and select opportunities rather than broad stock buying. For investors, consider whether a Buffett-like patient, long-horizon approach fits your risk tolerance rather than chasing quick gains.
  • UBS Boosts YETI Price Target to $38; Neutral Rating Amid Mixed Analyst Views
    November 8, 2025, 2:20 PM EST. UBS Group boosted YETI's price target from $35.00 to $38.00 with a neutral rating, implying about a 6.35% upside from the current level. The note follows a string of analyst moves, including Morgan Stanley lifting their target to $39 and maintaining an equal weight stance, Jefferies reiterating a buy, and Raymond James boosting their objective to $37 while reiterating an outperform view. Market consensus from MarketBeat shows a Hold rating with a $38.83 target. YETI traded around $35.73, up about $0.60 on Friday, with volume near 1.34M. Fundamentals: debt-to-equity 0.09, P/E 17.07, P/E/G 2.36, beta 1.89. Q1 results beat on EPS ($0.61) and revenue ($487.77M). FY2025 guidance: $2.38-$2.49; analysts expect about $2.57 for the year. Hedge funds also added to holdings in Q1.
Pfizer (PFE) Clinches $10B Metsera Deal, Beating Novo Nordisk — What the Winning Bid Means for the Obesity-Drug Race (Nov. 8, 2025)
Previous Story

Pfizer (PFE) Clinches $10B Metsera Deal, Beating Novo Nordisk — What the Winning Bid Means for the Obesity-Drug Race (Nov. 8, 2025)

Breaking: Eos Energy & MN8 Secure Huge 750 MWh U.S. Battery Storage Deal – Are Stocks Set to Skyrocket?
Next Story

Eos Energy (EOSE) News Today: Price Target Uplift, Fresh Downgrade, and 70% Warrant Surge — What’s Moving the Stock (Nov 8, 2025)

Go toTop